We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$3.56M
Cap. Flow
-$2.69M
Cap. Flow %
-2.11%
Top 10 Hldgs %
73.57%
Holding
78
New
20
Increased
12
Reduced
12
Closed
22

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$4.36M
2
CELC icon
Celcuity
CELC
+$3.08M
3
FCX icon
Freeport-McMoran
FCX
+$2.33M
4
AMZN icon
Amazon
AMZN
+$1.85M
5
AAOI icon
Applied Optoelectronics
AAOI
+$1.65M

Top Sells

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$2.68M
2
FIGR
Figure Technology Solutions
FIGR
+$2.35M
3
SPOT icon
Spotify
SPOT
+$2.32M
4
XOM icon
ExxonMobil
XOM
+$1.82M
5
NUVB icon
Nuvation Bio
NUVB
+$1.79M

Sector Composition

Rank Sector Weight
1 Healthcare 61.65%
2 Energy 24.24%
3 Consumer Discretionary 5.4%
4 Technology 4.57%
5 Materials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIR icon
26
Vir Biotechnology
VIR
$1.45B
$576K 0.45%
+64,300
New +$512K
CRCL
27
Circle Internet Group
CRCL
$15.3B
$572K 0.45%
+6,000
New +$509K
HCC icon
28
Warrior Met Coal
HCC
$4.2B
$559K 0.44%
6,000
-6,000
-50% -$540K
PATH icon
29
UiPath
PATH
$6.59B
$555K 0.44%
50,000
+3,000
+6% +$38.2K
SRRK icon
30
Scholar Rock
SRRK
$5.68B
$531K 0.42%
10,800
-1,200
-10% -$53.8K
WGS icon
31
GeneDx Holdings
WGS
$1.99B
$514K 0.4%
8,000
+5,000
+167% +$456K
MU icon
32
Micron Technology
MU
$961B
$507K 0.4%
+1,500
New +$588K
NVDA icon
33
NVIDIA
NVDA
$4.83T
$488K 0.38%
+2,800
New +$514K
REPL icon
34
Replimune Group
REPL
$899M
$470K 0.37%
61,500
– –
RGNX icon
35
Regenxbio
RGNX
$624M
$469K 0.37%
56,000
-26,500
-32% -$278K
PALI icon
36
Palisade Bio
PALI
$327M
$451K 0.35%
257,500
+107,500
+72% +$195K
OLMA icon
37
Olema Pharmaceuticals
OLMA
$1.01B
$373K 0.29%
25,000
-28,500
-53% -$634K
GLUE icon
38
Monte Rosa Therapeutics
GLUE
$1.36B
$370K 0.29%
+22,500
New +$430K
ONDS icon
39
Ondas Inc
ONDS
$4.23B
$339K 0.27%
+37,500
New +$408K
ACOG
40
Alpha Cognition
ACOG
$177M
$283K 0.22%
51,500
– –
MBX
41
MBX Biosciences
MBX
$3.14B
$269K 0.21%
+9,000
New +$306K
APC
42
ARKO Petroleum
APC
$955M
$268K 0.21%
+15,000
New +$278K
KYTX icon
43
Kyverna Therapeutics
KYTX
$444M
$259K 0.2%
30,000
+4,900
+20% +$40.8K
RYZ
44
Ryerson Holding Corp
RYZ
$1.47B
$243K 0.19%
+10,800
New +$282K
NKLR
45
Terra Innovatum Global N.V.
NKLR
$606M
$209K 0.16%
45,000
– –
INCY icon
46
Incyte
INCY
$24.3B
$188K 0.15%
+2,000
New +$200K
CAPR icon
47
Capricor Therapeutics
CAPR
$227M
$152K 0.12%
5,000
+3,500
+233% +$93.3K
VPG icon
48
Vishay Precision Group
VPG
$1.25B
$130K 0.1%
+3,000
New +$135K
ESPR
49
DELISTED
Esperion Therapeutics
ESPR
$130K 0.1%
47,500
– –
AMLX icon
50
Amylyx Pharmaceuticals
AMLX
$2.2B
$125K 0.1%
9,000
– –
1
2
3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
IFA
Interactive Financial Advisors New Lenox, Illinois $153M AUM 13.94% 1-Year Est. Return
BGAI
Bruce G. Allen Investments Denver, Colorado $153M AUM 23.23% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
EG
Ellerson Group Annapolis, Maryland $153M AUM 41.08% 1-Year Est. Return

ACT Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, ACT Capital Management held 78 positions worth $127M, up 2.9% from $124M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

ACT Capital Management's Q1 2026 filing shows 20 new, 12 increased, 12 reduced and 22 closed positions. Its largest new stake was Alumis Inc: 174,250 shares worth $3.84M. The largest sale was Structure Therapeutics, an estimated $2.68M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Energy and Consumer Discretionary.

  • ACT Capital Management's largest Q1 2026 buy was Alumis Inc: 174,250 shares worth $3.84M.
  • ACT Capital Management added most to Celcuity in Q1 2026, an estimated $3.08M increase.
  • ACT Capital Management's biggest Q1 2026 reduction was ExxonMobil, cutting an estimated $1.82M.
  • ACT Capital Management fully exited Structure Therapeutics in Q1 2026, selling an estimated $2.68M.
  • ACT Capital Management's ten largest holdings make up 74% of its $127M portfolio in Q1 2026.
  • ACT Capital Management opened 20 new positions and closed 22 in Q1 2026.
  • ACT Capital Management's portfolio value rose 2.9% quarter-over-quarter to $127M.

Based on ACT Capital Management's 13F filing for Q1 2026, filed 8 May 2026.